When it comes to building effective collaborations, we value the nimbleness, passion and creativity that characterise small biotech companies, as well as the stability of established organisations.

We look for programmes that can move us forward in key areas. At the same time, we respect the rights and needs of partner companies. We are transparent on each programme’s origins and on the nature of the collaboration. We also recognise that small companies grow, and support ongoing changes to our partners’ capabilities and resources.

Our areas of interests are:

NEUROLOGY
Our neurology group seeks disease-modifying therapeutics for neurodegenerative diseases.

HAEMATOLOGY
Our haematology group seeks therapeutics for non-malignant hematological diseases.

IMMUNOLOGY
Our immunology group focuses on autoimmune, inflammatory and fibrotic diseases.

PULMONARY, TISSUE INJURY AND FIBROSIS
Our pulmonary, tissue injury and fibrosis group focuses on the molecular and cellular mechanisms that drive tissue-injury response and regulate repair.

PLATFORM TECHNOLOGIES
Biogen seeks platform technologies in a variety of areas (e.g., target discovery, drug targeting and delivery, biomarkers, manufacturing/engineering, imaging and digital technology).

Have a potential opportunity for collaboration? Contact us.